ProShare Advisors’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Sell |
27,732
-25,455
| -48% | -$542K | ﹤0.01% | 1036 |
|
|
2025
Q1 | $1.03M | Sell |
53,187
-7,643
| -13% | -$147K | ﹤0.01% | 804 |
|
|
2024
Q4 | $1.09M | Buy |
60,830
+1,474
| +2% | +$26.3K | ﹤0.01% | 875 |
|
|
2024
Q3 | $1.3M | Buy |
59,356
+499
| +0.8% | +$10.9K | ﹤0.01% | 741 |
|
|
2024
Q2 | $459K | Sell |
58,857
-11,138
| -16% | -$86.9K | ﹤0.01% | 1029 |
|
|
2024
Q1 | $290K | Buy |
69,995
+6,035
| +9% | +$25K | ﹤0.01% | 1446 |
|
|
2023
Q4 | $167K | Buy |
63,960
+3,295
| +5% | +$8.6K | ﹤0.01% | 1682 |
|
|
2023
Q3 | $113K | Buy |
60,665
+451
| +0.7% | +$843 | ﹤0.01% | 1611 |
|
|
2023
Q2 | $151K | Buy |
60,214
+11,844
| +24% | +$29.7K | ﹤0.01% | 1610 |
|
|
2023
Q1 | $84.6K | Buy |
48,370
+31,719
| +190% | +$55.5K | ﹤0.01% | 1620 |
|
|
2022
Q4 | $70.8K | Sell |
16,651
-274
| -2% | -$1.17K | ﹤0.01% | 1702 |
|
|
2022
Q3 | $20K | Buy |
+16,925
| New | +$20K | ﹤0.01% | 1716 |
|
|
2022
Q2 | – | Sell |
-15,054
| Closed | -$37K | – | 2088 |
|
|
2022
Q1 | $37K | Sell |
15,054
-4,464
| -23% | -$11K | ﹤0.01% | 2134 |
|
|
2021
Q4 | $52K | Sell |
19,518
-4,663
| -19% | -$12.4K | ﹤0.01% | 2280 |
|
|
2021
Q3 | $121K | Buy |
24,181
+877
| +4% | +$4.39K | ﹤0.01% | 1888 |
|
|
2021
Q2 | $174K | Buy |
23,304
+11,879
| +104% | +$88.7K | ﹤0.01% | 2182 |
|
|
2021
Q1 | $67K | Sell |
11,425
-1,271
| -10% | -$7.45K | ﹤0.01% | 2205 |
|
|
2020
Q4 | $60K | Buy |
+12,696
| New | +$60K | ﹤0.01% | 2034 |
|